Viridian Therapeutics Inc
F:1S1
Viridian Therapeutics Inc
F:1S1
Price:
11.2
EUR
-2.61%
Market Closed
Market Cap:
€714.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Viridian Therapeutics Inc
F:1S1
|
US |
|
M
|
Mycronic AB (publ)
OTC:MICLD
|
SE |
|
Crescita Therapeutics Inc
TSX:CTX
|
CA |
|
Meta Platforms Inc
MIL:1FB
|
US |
|
O
|
Orbital Corporation Ltd
F:OREA
|
AU |
|
U
|
UPM-Kymmene Oyj
XMUN:RPL
|
FI |
|
G
|
Gemdale Gold Inc
XTSX:GEMG
|
CA |
|
T
|
TJX Companies Inc
SWB:TJX
|
US |
|
G
|
Genuine Parts Co
SWB:GPT
|
US |
|
U
|
Under Armour Inc
F:U9R
|
US |
|
Q
|
Quest Diagnostics Inc
F:QDI
|
US |
|
P
|
People's Insurance Company Group of China Ltd
F:PIR
|
CN |
|
C
|
China Life Insurance Co Ltd
DUS:CHL
|
CN |
|
C
|
CBRE Group Inc
XMUN:RF6
|
US |
|
F
|
Federal National Mortgage Association
XMUN:FNM
|
US |
|
F
|
Franklin Resources Inc
F:FRK
|
US |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
L
|
Lam Research Corp
SWB:LAR
|
US |
|
Almonty Industries Inc
F:ALI0
|
CA |
|
Xcel Energy Inc
NASDAQ:XEL
|
US |
|
H
|
Heidelberg Pharma AG
XBER:HPHA
|
DE |
|
A
|
Akwel SA
SWB:MW4
|
FR |
|
T
|
Travelers Companies Inc
F:PA9
|
US |
|
S
|
Starwood Property Trust Inc
XBER:VSP
|
US |
Wall St Price Targets
1S1 Price Targets Summary
Viridian Therapeutics Inc
Viridian Therapeutics Inc
Wall Street analysts forecast 1S1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1S1 is 44.54 EUR with a low forecast of 26.45 EUR and a high forecast of 72.35 EUR.
Lowest Forecast
Price Target
26.45
EUR
136% Upside
Average Forecast
Price Target
44.54
EUR
298% Upside
Highest Forecast
Price Target
72.35
EUR
546% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S1's stock price target?
Price Target
44.54
EUR
44.54
EUR
According to Wall Street analysts, the average 1-year price target for 1S1 is 44.54 EUR with a low forecast of 26.45 EUR and a high forecast of 72.35 EUR.
What is the Revenue forecast for Viridian Therapeutics Inc?
Projected CAGR
45%
45%
Over the last 13 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 45%.
